Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0409-4283

8 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-4283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Lidocaine 01)

FDA Label Image

Structural Formula Lidocaine Hydrochloride (Lidocaine 02)

Structural Formula Lidocaine Hydrochloride (Lidocaine 02)
Chemical structure of Lidocaine Hydrochloride, showing the molecular formula with aromatic ring, methyl groups, and hydrochloride and water components.*
FDA Label Image

Hospira Logo (Lidocaine 03)

FDA Label Image

Principal Display Panel (5 mL Ampule Label)

Principal Display Panel (5 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection, USP 4% (200 mg/5 mL or 40 mg/mL) preservative-free solution. The 5 mL single-dose product is indicated for topical use and retrobulbar injection. Distributed by Hospira, Inc., Lake Forest, IL, USA, with NDC 0409-4283-11. Rx only.*
FDA Label Image

Principal Display Panel (5 mL Ampule Cello Pack Label)

Principal Display Panel (5 mL Ampule Cello Pack Label)
Label for Lidocaine HCl Injection, USP, 4% (200 mg/5 mL, 40 mg/mL), preservative-free solution. The product is in 5 single-dose ampuls, labeled for topical use and retrobulbar injection. Manufactured and distributed by Hospira, Inc., the label includes NDC 0409-4283-25 and storage instructions at controlled room temperature.*
FDA Label Image

Principal Display Panel (200 mg/5 mL Ampule Label)

Principal Display Panel (200 mg/5 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection USP, 200 mg per 5 mL (40 mg/mL), single-dose vial designed for topical and retrobulbar use. The label indicates preservative-free formulation, Rx only status, and distribution by Hospira, Inc., Lake Forest, IL.*
FDA Label Image

Principal Display Panel (200 mg/5 mL Calmshell Label)

Principal Display Panel (200 mg/5 mL Calmshell Label)
Label for Lidocaine Hydrochloride Injection, USP 4% solution, 200 mg/5 mL (40 mg/mL) single-dose ampuls. The label indicates preservative-free formulation, approved for topical and retrobulbar injection. It includes dosage strength, pH adjustment notes, storage instructions at controlled room temperature (20-25°C), and the labeler Hospira, Inc.*
FDA Label Image

Principal Display Panel (200 mg/5 mL Carton Label)

Principal Display Panel (200 mg/5 mL Carton Label)
Packaging label for Lidocaine HCl Injection, USP 4% (200 mg/5 mL) preservative-free solution. The label indicates a 5 mL single-dose ampule, for topical use and retrobulbar injection. The product is distributed by Hospira, Inc., and includes NDC 0409-4283-15. The label details sterile single-dose ampules, storage instructions, and the preservative-free formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.